Medifast (MED) Tops Q2 EPS by 3c, Revenues Beat; Raises FY19 EPS/Revenue Guidance
Tweet Send to a Friend
Medifast (NYSE: MED) reported Q2 EPS of $1.75, $0.03 better than the analyst estimate of $1.72. Revenue for the quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
